Why Dose Equivalency Matters for Your Treatment Choice
Understanding Mounjaro Equivalent Dose to Wegovy: Key Differences
When comparing Mounjaro equivalent dose to wegovy, it's essential to understand that these medications work through different mechanisms and cannot be directly substituted dose-for-dose. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors as a dual agonist. The dosing schedules differ significantly, with Wegovy escalating from 0.25mg weekly to 2.4mg maintenance over 16 weeks, compared to Mounjaro's progression from 2.5mg to 15mg maximum over 20 weeks. Understanding these differences helps patients and prescribers choose the most appropriate treatment pathway.
At EverydayMeds, we recognise that finding the right mounjaro equivalent dose to wegovy comparison requires expert clinical guidance rather than simple dose conversion. Our GPhC-registered pharmacy (#9012878) stocks the complete Wegovy range, allowing your prescriber to initiate treatment at the appropriate starting dose and adjust according to your individual response. Both medications require careful dose escalation to minimise gastrointestinal side effects, and our clinical team provides ongoing support throughout your treatment journey.
Complete Wegovy Dosing Schedule: Every Stage Available
Our comprehensive Wegovy dosing programme ensures you have access to every stage of treatment without interruption. The escalation begins with 0.25mg for weeks 1-4 at £79.99, progressing to 0.5mg for weeks 5-8 at £94.99, then 1mg for weeks 9-12 at £99.99, followed by 1.7mg for weeks 13-16 at £139.99, and finally reaching the 2.4mg maintenance dose from week 17 onwards at £209.99. New customers can apply code FIRST40 at checkout, whilst returning customers use DOSE25 for continued support. Our Intro Duo bundle combines the first two doses (0.25mg & 0.5mg) for £169.99, providing seamless coverage for your initial 8 weeks of treatment.
For patients requiring extended time at lower doses, our Gentle Start Trio includes 0.25mg, 0.25mg, and 0.5mg pens for £269.99, allowing a more gradual introduction. The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring consistent treatment once you've reached your target dose. This comprehensive approach eliminates the need to source different doses from multiple pharmacies during your weight management journey.
Clinical Evidence Supporting Wegovy Dosing Strategy
The structured Wegovy dose escalation protocol is based on extensive clinical evidence from the STEP trial programme. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The gradual dose increases help patients adapt to the medication whilst maximising therapeutic benefits and minimising gastrointestinal side effects.
Recent SELECT trial data demonstrated that Wegovy may reduce major cardiovascular events by 20% in patients with established cardiovascular disease, highlighting benefits beyond weight management. These clinical outcomes support the importance of reaching and maintaining the optimal therapeutic dose through the structured escalation protocol that EverydayMeds facilitates with complete dose availability.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a natural hormone that regulates appetite and food intake. When administered weekly via the FlexTouch pen device, semaglutide binds to GLP-1 receptors in the brain's appetite centres, promoting feelings of satiety and reducing food cravings. This mechanism helps patients feel fuller after smaller meals and may reduce between-meal snacking, supporting adherence to reduced-calorie dietary plans. The medication slows gastric emptying, prolonging the feeling of fullness after eating, whilst also influencing reward pathways associated with food preference. These combined effects support sustainable weight management when used alongside increased physical activity and dietary modifications.
Streamlined Ordering Process for All Doses
Accessing any Wegovy dose through EverydayMeds begins with our 3-minute online clinical assessment, designed to evaluate your suitability for prescription weight management treatment. Our qualified prescribers review your assessment within 3 working days as standard, or within 24 hours with our express service, ensuring rapid access to treatment. Once approved, your Wegovy pen is dispatched via next-day delivery using temperature-controlled packaging to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) operates to the highest standards of clinical governance, with ongoing prescriber support available throughout your treatment. The process includes regular review opportunities to assess treatment response and adjust dosing as clinically appropriate.
Storage and Practical Considerations
Proper Wegovy storage is crucial for maintaining medication effectiveness throughout the dose escalation period. Each FlexTouch pen must be stored in the refrigerator at 2-8°C before first use, though it can remain at room temperature below 30°C for up to 6 weeks once removed from refrigeration. This storage flexibility provides a significant advantage over some alternative treatments, such as Mounjaro, which can only be stored at room temperature for 21 days. The pre-filled pen design eliminates the need for online pharmacy dose measurement, with clear dosing windows showing the selected weekly injection amount. Each pen contains four weekly doses, with dose escalation occurring every 4 weeks according to the structured protocol, making treatment management straightforward and consistent.
Why Complete Dose Availability Matters for Mounjaro vs Wegovy Decisions
Having access to every Wegovy dose eliminates treatment interruptions that can compromise weight management outcomes. When comparing mounjaro equivalent dose to wegovy options, patients benefit from knowing their chosen pharmacy can support the entire treatment journey without requiring transfers or dose substitutions. EverydayMeds' comprehensive stock holding means prescribers can confidently initiate Wegovy treatment knowing that dose escalations and maintenance supply are assured.
This continuity becomes particularly important for patients who may need to remain at intermediate doses longer than the standard protocol suggests, or those requiring step-down approaches due to side effects. Our flexible bundling options, including the Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99, support individualised treatment pathways whilst maintaining cost-effectiveness compared to purchasing single pens separately.
Making Your Treatment Choice: Expert Support Available
Choosing between Mounjaro and Wegovy requires consideration of individual factors including medical history, lifestyle preferences, and treatment goals. Both medications are prescription-only medicines requiring clinical assessment and ongoing monitoring for safety and effectiveness. At EverydayMeds, our clinical team provides expert guidance on mounjaro equivalent dose to wegovy comparisons, helping you understand which treatment pathway may be most suitable for your circumstances. We maintain comprehensive stock of all Wegovy doses alongside expert prescriber support, ensuring seamless treatment initiation and continuation. Your journey begins with our clinical assessment at https://everydaymeds.co.uk/collections/wegovy, where our qualified prescribers can evaluate your individual needs and recommend the most appropriate treatment approach. Remember to use code FIRST40 for new customers or DOSE25 for returning patients when completing your assessment.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
